Study of Tryptophan Hydroxylase 2 Gene Variants in Methamphetamine Dependence
Author Information
Author(s): Kobayashi Hideaki, Ujike Hiroshi, Iwata Nakao, Inada Toshiya, Yamada Mitsuhiko, Sekine Yoshimoto, Uchimura Naohisa, Iyo Masaomi, Ozaki Norio, Itokawa Masanari, Sora Ichiro
Primary Institution: Tohoku University Graduate School of Medicine
Hypothesis
Are variations in the TPH2 gene associated with methamphetamine dependence and psychosis in a Japanese population?
Conclusion
The study found no significant association between TPH2 gene variants and methamphetamine dependence or psychosis.
Supporting Evidence
- Ten single nucleotide polymorphisms (SNPs) and two insertion/deletion polymorphisms were identified in the TPH2 gene.
- No significant differences were found in the genotypic or allelic frequencies between patients and controls.
- The study included a total of 162 patients and 243 controls.
Takeaway
The researchers looked at a gene that helps make serotonin to see if it affects people who are addicted to methamphetamine, but they found it doesn't seem to matter.
Methodology
The study analyzed DNA from 162 patients with methamphetamine dependence/psychosis and 243 controls, looking for polymorphisms in the TPH2 gene.
Limitations
The study was limited to a specific population and may not generalize to other groups.
Participant Demographics
162 patients (130 males, 32 females; mean age 37.4 years) and 243 controls (168 males, 75 females; mean age 35.4 years), all Japanese.
Statistical Information
P-Value
0.448
Statistical Significance
p=0.448
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website